R&D

News

Novartis CAR-T safety in FDA spotlight

FDA advisers are set to make recommendations on Novartis’ groundbreaking CAR-T therapy CTL019 tomorrow – and are set to focus on safety concerns in the decisive meeting.

News

EMA and FDA aim to slash Gaucher disease R&D costs

Proposals include multi-company trial.

News

A sad young woman is sitting in her kitchen with a headache

Alder shares slump despite migraine success

Investors concerned over strong placebo effect

News

Merck & Co hit by GoldenEye ransomware

Attack overshadows surprise success for cholesterol drug

News

CRUK launches next phase of cancer 'Grand Challenge'

Charity launches second set of research challenges.

News

Clovis looks for new drugs after Rubraca success

US biotech looks to bolster pipeline.

Novartis CAR-T safety in FDA spotlight

EMA and FDA aim to slash Gaucher disease R&D costs

Alder shares slump despite migraine success

Merck & Co hit by GoldenEye ransomware

CRUK launches next phase of cancer 'Grand Challenge'

Clovis looks for new drugs after Rubraca success

Wnt drug gives MSD first eye disease win after EyeBio deal

Discover a new era of healthcare panel engagement: Grounded ...

R&amp;D

Editor's Picks

R&D